Haifeng Shi | Infectious Diseases | Excellence in Research

Posted on 12/10/202412/10/2024 by PencisLeave a Comment

Dr. Haifeng Shi | Infectious Diseases | Excellence in Research

Jiangsu University | China

Author Profile

Dr. Shi Haifeng: Pioneer in Metal Toxicology and Cell Damage Detection 🔬

EARLY ACADEMIC PURSUITS 🎓

Dr. Shi Haifeng's academic journey began with a Bachelor’s degree in Biochemistry from Nanjing University in 1998. His passion for biochemistry led him to pursue a Ph.D. at the Hong Kong University of Science and Technology, where he studied under the mentorship of Professor Hong Xue, earning his doctorate in 2002. This foundation set the stage for his future groundbreaking research in the field of metal ion metabolism and toxicity.

PROFESSIONAL ENDEAVORS 🧑‍🔬

After obtaining his Ph.D., Dr. Shi continued his work at the Hong Kong University of Science and Technology as a Research Associate from 2002 to 2004, further honing his research skills. He then embarked on an international academic experience as a Visiting Scholar at the National Institutes of Health (NIH), specifically within the Liver Diseases Branch of the NIDDK, from 2004 to 2009. His time at the NIH allowed him to deepen his expertise in molecular toxicology and disease mechanisms.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🧪

Dr. Shi’s research is focused on the metabolism and biological toxicity of metal ions such as iron, copper, and cadmium. His work is crucial in understanding how these metals impact biological systems, particularly in the context of heavy metal nephropathy. Additionally, his innovative work on the use of cell-free circulating cfDNA in blood as a biomarker for tissue cell damage has broad applications in medical diagnostics and environmental toxicology. His experimental models, which include yeast, silkworms, and mice, have helped to clarify the toxicological effects of metals at both molecular and systemic levels.

IMPACT AND INFLUENCE 🌍

Dr. Shi’s contributions to the scientific community are widely recognized. He has published over 70 research papers in prestigious international journals. One of his papers was recommended by Professor Alan Parrish from the University of Missouri-Columbia and listed by "Faculty Opinions" (formerly F1000Prime), a distinction reserved for papers with significant impact on their field. Another of his publications has been selected as an ESI Highly Cited Paper, placing him among the top 1% of researchers in his field.

ACADEMIC CITATIONS 📚

Dr. Shi’s work is highly cited, and his recognition as an ESI Highly Cited Researcher underscores his influence on the global scientific community. His papers continue to guide researchers in the fields of toxicology, nephropathy, and medical diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Dr. Shi Haifeng’s legacy lies in his groundbreaking work on the biological effects of heavy metals and his innovative use of cfDNA in disease detection. As a leader in his field, his future contributions are expected to expand the frontiers of biochemistry and toxicology, with significant implications for both environmental health and clinical medicine. His continued dedication to both research and education ensures that he will remain an influential figure in his field for years to come.

NOTABLE PUBLICATIONS 📑

"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy"

Authors: Guo, C. , Ruan, J. , Li, Z. , Gu, J. , Shi, H.
Journal: Ecotoxicology and Environmental Safety
Year: 2024

"From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death"

Authors: Gu, J. , Guo, C. , Ruan, J. , Gong, X. , Shi, H.
Journal: Apoptosis
Year: 2024

"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release"

Authors: Xu, L. , He, L. , Li, Y. , Shi, H. , Zhu, C.
Journal: Biomedical Materials (Bristol)
Year: 2024

"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers"

Authors: Xu, L. , Li, Y. , Cai, T. , Chu, Z. , Shen, X
Journal: Macromolecular Research
Year: 2024

"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation"

Authors: Cao, C. , Yuan, L. , Wang, Y. , Shi, H. , Jiang, T.
Journal: Frontiers in Immunology
Year: 2024

Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award

Posted on 30/09/202430/09/2024 by PencisLeave a Comment

Dr. Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award

Dermopathic Institute of the Immaculate, IDI-IRCC | Italy

Author Profile

Scopus

Orcid ID

Google Scholar

🌟 Biography of Giulia Pascolini, MD, PhD

🎓 EARLY ACADEMIC PURSUITS

Giulia Pascolini's journey in medical science began with a Degree in Medicine from Sapienza University of Rome in 2008, which she completed with honors. Following this, she pursued specialization in Medical Genetics at Tor Vergata University of Rome, graduating with honors in 2015 after five years of in-depth study. Driven by her passion for genetics, Dr. Pascolini went on to earn her Ph.D. in Medical Genetics from Sapienza University in 2019, establishing her expertise in a rapidly advancing field. In 2022, she further expanded her knowledge with a Master of II level in Rare Diseases, also from Sapienza University, solidifying her role as a leading expert in rare genetic disorders.

🩺 PROFESSIONAL ENDEAVORS

Dr. Pascolini's professional career is marked by extensive experience across multiple prestigious institutions. Currently, she is a Clinical Geneticist and head of the Clinical Genetics Service at the Istituto Dermopatico dell'Immacolata (IDI-IRCCS) in Rome, Italy. Since September 2023, she also holds a position as Professor of Medical Genetics at the Faculty of Medicine and Surgery at Tor Vergata University of Rome. Over the years, she has held various roles, including serving as a clinical geneticist at Bambino Gesù Children’s Hospital and a researcher at San Camillo-Forlanini Hospital. Her long-standing commitment to clinical genetics spans over 15 years, with a focus on intellectual disability syndromes, dysmorphology, and developmental disorders.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON NEURODEVELOPMENTAL DISORDERS

Dr. Pascolini's research primarily centers around Developmental Disorders of Chromatin Remodeling (DDCRs), intellectual disability (ID) syndromes, and genodermatoses. She has played a crucial role in the study of the skin phenotype in rare genetic diseases, and her work on deep learning technologies for diagnosing genetic syndromes using facial phenotype recognition is groundbreaking. Her involvement with FDNA Inc. and the DeepGestalt technology is a testament to her contributions to advancing medical genetics through innovative platforms. She is also a principal investigator for multiple research projects, including studies on rare cutaneous tumors and familial melanoma, with funding of over €47,000 for these projects.

🌍 IMPACT AND INFLUENCE

As a Scientific Board Member of the ADNP Syndrome Italian Association and an editorial board member of the Journal of Pediatric Genetics, Dr. Pascolini has made significant contributions to the broader medical community. Her work has helped shape new approaches to the clinical understanding of complex genetic disorders, particularly in rare diseases and neurodevelopmental syndromes. Through her collaborative efforts with international organizations and her academic roles, she continues to influence both current medical practices and future research directions.

📚 ACADEMIC CITES AND PUBLICATIONS

Dr. Pascolini has authored several impactful works, including her involvement in the DeepGestalt technology article on SETD5-associated intellectual disability published in the Journal of Translational Genetics and Genomics. Her contributions to book chapters, such as her writing on Genomic Copy Number Variants (CNVs) and Autism Spectrum Disorder (ASD), have added substantial value to academic literature. Her expertise has also been recognized through invitations to write for special issues in leading journals, enhancing her standing as a key voice in her field.

🏅 AWARDS AND RECOGNITION

In 2019, Dr. Pascolini was awarded the Franca Dagna Bricarelli Award for her clinical research on genetic mutations associated with the BAF complex. This prestigious award highlights her excellence in medical genetics and clinical research. Her contributions to the field, recognized by peers and institutions alike, reflect her profound impact on the study and treatment of genetic disorders.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

With her leadership in clinical genetics, active research on rare skin diseases, and innovative work in genetic syndrome diagnostics, Dr. Pascolini is poised to continue shaping the future of medical genetics. Her contributions to understanding the genetic basis of intellectual disabilities and her work on cutting-edge diagnostic technologies ensure her legacy as a pioneering figure in genetics. As she continues her role in both clinical and academic settings, her future contributions will likely further advance the study and treatment of rare genetic conditions, helping countless individuals worldwide.

📑NOTABLE PUBLICATIONS

"The face of Non-photosensitive trichothiodystrophy phenotypic spectrum: A subsequent study on paediatric population"

Authors: Pascolini, G. , Lipari, M. , Gaudioso, F. , Di Zenzo, G. , Didona, B.
Journal: Molecular Genetics and Genomic Medicine
Year: 2024

"Usmani-Riazuddin syndrome can have a recognizable phenotype: Report of a novel AP1G1 variant"

Authors: Gnazzo, M. , Pascolini, G. , Parlapiano, G. , Novelli, A. , Baban, A.
Journal: Clinical Genetics
Year: 2024

"Extended phenotypic characterization of a novel Helsmoortel-van der Aa syndrome case series"

Authors: Pascolini, G., Di Zenzo, G., Panebianco, A., Didona, B., Gozes, I.
Journal: American Journal of Medical Genetics
Year: 2024

"Ectoderm-derived findings in Aymè-Gripp syndrome"

Authors: Pascolini, G., Di Zenzo, G., Morani, P., Didona, B., Panebianco, A.
Journal: Journal of Dermatology
Year: 2024

"Defining the clinical spectrum of ichthyosis follicularis, atrichia and photophobia clinical association type 1 (IFAP1)"

Authors: Pascolini, G., Fortugno, P., Chandramouli, B., Didona, B., Castiglia, D.
Journal: European Journal of Dermatology
Year: 2023

Li Wan | Bipolar Disorder | Best Researcher Award

Posted on 10/08/202410/08/2024 by PencisLeave a Comment

Prof Li Wan | Bipolar Disorder | Best Researcher Award

Affiliated Psychological Hospital Of Anhui Medical University | China

Author Profile

Scopus

Orcid ID

Dr. Li Wan: Expert in Cognitive Neuropsychology and Neuromodulation 🧠

Educational Background 🎓

Ph.D. in Psychology (2006) - Virginia Polytechnic Institute and State University, Virginia, USA
Master of Psychology (2004) - Virginia Polytechnic Institute and State University, Virginia, USA
Bachelor of Clinical Medicine (1998) - Hubei University of Medicine, Hubei, China

Professional Experience 💼

Adjunct Professor (2022-present) - Anhui Medical University, Hefei, China
Director (2021-present) - Brain Disorders and Neuromodulation Research Center, Anhui Mental Health Center, Hefei, China
Co-Principal Investigator (2018-2021) - Cognitive Neuropsychology Lab, University of Science and Technology of China, Hefei, China
Research Scientist (2014-2018) - School of Medicine, University of Missouri-Kansas City; Center for Behavioral Medicine/Department of Mental Health, Missouri, USA
Clinical Assistant Professor/Post-doc Fellow (2007-2013) - Department of Psychiatry and Behavioral Science, Texas A&M University and Central Texas Veterans Health Care System; Department of Psychology and Neuroscience, Baylor University, Texas, USA
Teaching/Research Assistant (2002-2006) - Department of Psychology, Virginia Tech, Virginia, USA

Fellowships & Honors 🏆

Anhui Province ‘Overseas High-level Talents’ Award (2019)
Fellowship, Athinoula A. Martinos Center for Biomedical Imaging, Harvard University (2010)
Travel Award, Graduate Student Association, Virginia Tech (2006)
Galper Fund Award, Department of Psychology, Virginia Tech (2005)
Multiple Travel Awards (2004-2006) - 1st, 2nd, and 3rd Joint ECNS and ISNIP Conferences
Graduate Research Development Project Grant, Virginia Tech (2003)

Affiliations & Memberships 🌐

Deputy Secretary - Sleep Branch, China Traditional Chinese Medicine Information Conference
Vice Director - Cognitive Behavioral Therapy Committee, Anhui Psychological Health Association
Member - World Psychiatric Association (WPA), Society for Psychophysiological Research (SPR), Cognitive Neuroscience Society (CNS)
Editorial Board Member - Brain Science Advances, Journal of Brain Research and Neurology, World Journal of Clinical Medicine Research, International Journal of Psychological and Brain Sciences, Advances in Health and Behavior
Reviewer - NeuroImage, Human Brain Mapping, Neural Regeneration Research, Psychophysiology, International Journal of Psychophysiology, Journal of Psychiatry Research, Psychiatry Research, and more

Journal Publications 📚

Dr. Li Wan has contributed significantly to the fields of psychology and neuroscience, with numerous publications in prestigious journals such as Heliyon, Human Brain Mapping, Frontiers in Psychology, Laboratory Medicine, and World Psychiatry. Her research covers a broad spectrum of topics, including affective disorders, brain morphology, cognitive neuropsychology, and the neural mechanisms underlying behavioral and psychiatric conditions.

Notable Publications 📑

"The neural mechanisms of immediate and follow-up of the treatment effect of hypnosis on smoking craving"

Authors: Li, X., Chen, L., Ma, R., Rao, H., Zhang, X.
Journal: Brain Imaging and Behaviour
Year: 2020

"The Effect of Vocabulary Depth and Breadth on English Listening Comprehension Can Depend on How Comprehension Is Measured "

Authors: Luo, Y., Song, H., Wan, L., Zhang, X.
Journal: Frontiers in Psychology
Year: 2021

"Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms "

Authors: Li, J., Wan, L., Feng, Y., Zhang, X., Xia, M
Journal: Lab Medicine
Year: 2021

"Brain morphology, harm avoidance, and the severity of excessive internet use"

Authors: Wan, L., Zha, R., Ren, J., Zuo, H., Zhang, X.
Journal: Human Brain Mapping
Year: 2022

"Decision tree distinguish affective disorder diagnosis from psychotic disorder diagnosis with clinical and lab factor"

Authors: Liu, X., Wang, X., Wen, C., Wan, L.
Journal: Heliyon
Year: 2022

Xiang Gui Yang | Clinical Microbiology | Best Researcher Award

Posted on 05/07/202405/07/2024 by PencisLeave a Comment

Xiang Gui Yang | Clinical Microbiology | Best Researcher Award

The First Affiliated hospital of Chengdu Medical College | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Yang Xianggui embarked on his academic journey at Harbin Medical University, where he earned a Bachelor's degree in Medical Laboratory Science. He further advanced his education at Chongqing Medical University, obtaining a Master's degree in Clinical Laboratory Diagnostics from the School of Laboratory Medicine.

PROFESSIONAL ENDEAVORS

Since July 2015, Yang Xianggui has been serving as the Deputy Chief Laboratory Physician at the First Affiliated Hospital of Chengdu Medical College. His primary focus is on research into bacterial resistance mechanisms and virulence, positioning him as a significant contributor to this critical field of medical research.

CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MICROBIOLOGY

Dr. Yang's research endeavors have been substantial and varied, including:

CRISPR/Cas9 Technology: Utilizing CRISPR/Cas9 to knock out the ftsZ gene in bacteria to study the molecular regulatory mechanism of the key enzyme MpI in the peptidoglycan cycle.
Gene Knockout Studies: Investigating the regulatory mechanism of acute-chronic infection transformation based on the nagZ gene knockout in Enterobacter cloacae.
MicroRNA Research: Exploring the application of miR-135 in detecting early-onset chronic kidney disease.
Enzyme and Protein Studies: Examining the correlation between Klebsiella pneumoniae KPC-2 enzyme and OmpK36, and studying the molecular regulatory mechanism of AmpC beta-lactamase, a key enzyme in the peptidoglycan cycle.

IMPACT AND INFLUENCE

Dr. Yang has been the principal investigator on several high-impact research projects funded by notable organizations:

National Natural Science Youth Foundation Project: CRISPR/Cas9 technology study on ftsZ gene knockout.
Sichuan Provincial Natural Science Foundation General Project: Regulatory mechanism study on acute-chronic infection transformation.
Sichuan Provincial Department of Education Fund: Research on miR-135's application in early-onset chronic kidney disease detection.
Chengdu Medical University Fund: Correlation study between Klebsiella pneumoniae KPC-2 enzyme and OmpK36.
Special Fund of the First Affiliated Hospital of Chengdu Medical College: Study on the molecular regulatory mechanism of AmpC beta-lactamase.

ACADEMIC CITES

Dr. Yang has published nine SCI papers as the first author or corresponding author, showcasing his contributions to the scientific community. His work is recognized and cited by peers, reflecting his influence and expertise in bacterial resistance mechanisms and clinical laboratory diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yang's ongoing research projects and completed studies contribute significantly to the understanding of bacterial resistance and virulence. His legacy is built on his dedication to advancing laboratory medicine through innovative research and collaborative efforts. Future contributions are anticipated in the areas of infection control, molecular diagnostics, and bacterial resistance management, further enhancing his impact on medical science and patient care.

IMPORTANT TOPICS

BACTERIAL RESISTANCE MECHANISMS: Exploring how bacteria develop resistance to antibiotics and identifying potential targets for new treatments.
VIRULENCE FACTORS: Investigating the components that make bacteria pathogenic and how they can be neutralized.
MOLECULAR REGULATORY MECHANISMS: Understanding the intricate molecular pathways that govern bacterial behavior and resistance.
GENE KNOCKOUT TECHNOLOGIES: Utilizing advanced gene-editing tools like CRISPR/Cas9 to study bacterial genetics and physiology.
CLINICAL APPLICATIONS: Translating research findings into practical applications in clinical diagnostics and treatment strategies.

NOTABLE PUBLICATIONS

PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection 2023(4)

Resistance of Klebsiella pneumoniae to Phage hvKpP3 Due to High-Molecular Weight Lipopolysaccharide Synthesis Failure 2023(3)

Application of Single-Cell Genomics in Cardiovascular Research 2023(2)

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex 2023(3)

Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression 2021(33)